Works from 2024
Breast cancer in the community, James Weese (Book Chapter)
Breast cancer: Multidisciplinary pathways for cancer care in the community, James Weese (Book)
Contemporary surgical approaches to breast cancer, Ashley Marumoto, Armando E. Guiliano, Ameer Gomberawalla, et al. (Book Chapter)
Expectations for the future, Amy Bock and James L. Weese (Book Chapter)
Initial findings from the DREAM-GI national database: Assessing the efficacy and safety of neoadjuvant immunotherapy (NIT) in patients with deficient mismatch repair/microsatellite instability-high (dMMR/MSI-H) gastrointestinal (GI) cancer, Sakti Chakrabarti, J. Eva Selfridge, Antony Ruggeri, et al. (Abstract)
Multidisciplinary team approach to the management of breast cancer, Aaron H. Chevinsky and Joseph John Weber (Book Chapter)
Noninferiority of hypofractionated vs conventional postprostatectomy radiotherapy for genitourinary and gastrointestinal symptoms: The NRG-GU003 phase 3 randomized clinical trial, Mark K. Buyyounouski, Stephanie L. Pugh, Ronald C. Chen, et al. (Article)
Outcomes and quality indicators, Joseph John Weber, Aaron H. Chevinsky, and Carol Huibregtse (Book Chapter)
PACE: A randomized phase II study of fulvestrant, palbociclib, and avelumab after progression on cyclin-dependent kinase 4/6 inhibitor and aromatase inhibitor for hormone receptor-positive/human epidermal growth factor receptor-negative metastatic breast cancer, Erica L. Mayer, Yue Ren, Nikhil Wagle, et al. (Article)
Radiation therapy, Kenneth T. Bastin, Ellen L. Ziaja, Greg Kauffmann, et al. (Book Chapter)
Systemic therapy for breast cancer, Sigrun Hallmeyer, Rubina Qamar, and Corey J. Shamah (Book Chapter)
Works from 2023
Analysis of local control outcomes and clinical prognostic factors in localized pelvic Ewing sarcoma patients treated with radiation therapy: A Report from the Children's Oncology Group, Safia K. Ahmed, Brent G. Witten, William S. Harmsen, et al. (Article)
Brief report on use of pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis, Monika A. Izano, Connor Sweetnam, Chenan Zhang, et al. (Article)
Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing, Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al. (Article)
Circulating tumor cells (CTCs) dynamics after CDK4/6i for hormone-receptor positive (HR+) metastatic breast cancer (MBC): A biomarker analysis of the PACE randomized phase II study, Lorenzo Gerratana, Yue Ren, Rubina Qamar, et al. (Abstract)
Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit, Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen, et al. (Article)
E372: Transhiatal esophagectomy with transcervical endoscopic esophageal mobilization is a minimally invasive approach with favorable oncologic and perioperative outcomes, Isaac R. Kriley, Noah Rozich, Rebecca Kirschner, et al. (Abstract)
E62: Analyzing the choosing wisely patient population: An NCDB study, Noah Rozich, Maharaj Singh, Nicole Zaremba, et al. (Abstract)
Evaluating pneumonitis incidence in patients with non-small cell lung cancer treated with immunotherapy and/or chemotherapy using real-world and clinical trial data, Qi Liu, Chenan Zhang, Yue Huang, et al. (Article)
Impact of donation after circulatory death allografts on outcomes following simultaneous liver-kidney transplant: A single-center experience and review of the literature, Shiva Kumar, Rachel Pedersen, and Ajay Sahajpal (Article)
Incidence of cardiac events in patients with MDS or AML receiving azacitidine or decitabine within a large community health system, Noor Naffakh, Michael Williams, Priyam Patel, et al. (Abstract)
Pulmonary open, robotic and thoracoscopic lobectomy (PORTaL) study: An analysis of 5,721 cases, Michael S Kent, Matthew G Hartwig, Eric Vallières, et al. (Article)
Pulmonary open, robotic and thoracoscopic lobectomy (PORTaL) study: Survival analysis of 6,646 cases, Michael S. Kent, Matthew G. Hartwig, Eric Vallières, et al. (Article)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Reducing Discharge Opioid Prescription After Breast Conservation Surgery: A Systemwide Multihospital Quality Improvement Initiative, Joseph J. Weber, Jodi Brehm, Julie Kepple, Meredith Witten, Nicole M. Zaremba, Carol Huibregtse, Anne Weers, and James L. Weese (Abstract)
Sclerosing Angiomatoid Nodular Transformation Appearing as Metastatic Disease in a Patient With Multiple Endocrine Neoplasia Type I, Rebecca C. Kirschner, Zane G. Staubach, and Wesley A. Papenfuss (Abstract)
Sclerosing Angiomatoid Nodular Transformation (SANT) Appearing as Metastatic Disease in a Patient With Multiple Endocrine Neoplasia Type I, Rebecca C. Kirschner, Zane G. Staubach, and Wesley A. Papenfuss (Poster)
Survival of Women Diagnosed With Stage IV Breast Cancer and Brain Metastases by Molecular Subtype, Maharaj Singh, Meredith Witten, and Richard Rovin (Abstract)
The efficacy and safety of neoadjuvant immunotherapy in patients with deficient mismatch repair/microsatellite instability–high (dMMR/MSI-H) localized and oligometastatic colon cancer: Data from the real world, Sakti Chakrabarti, Marie Parish, Carrie Peterson, et al. (Abstract)
Transhiatal Esophagectomy With Transcervical Endoscopic Esophageal Mobilization is a Minimally Invasive Technique for Esophagectomy With Favorable Oncologic and Perioperative Outcomes, Isaac R. Kriley, Noah Rozich, Rebecca Kirschner, James Adefisoye, Amanda Mueller, Elizabeth Colwell, Geoffrey Bellini, David Demos, William Tisol, and Wesley Papenfuss (Poster)
Works from 2022
Analysis of local control outcomes and clinical prognostic factors in localized pelvic Ewing Sarcoma patients treated with radiation therapy: A report from the Children's Oncology Group, S K. Ahmed, Brent Witten, W S. Harmsen, et al. (Abstract)
Assessment of regional variability in COVID-19 outcomes among patients with cancer in the United States, Jessica E. Hawley, Mitrianna Streckfuss, Michael A. Thompson, et al. (Article)
A statewide approach to reducing re-excision rates for women with breast conserving surgery, Jessica R. Schumacher, Elise H. Lawson, Amanda L. Kong, et al. (Article)
Blood and marrow transplantation (BMT) within four weeks of Sars-Cov-2 infection is associated with increased risk of mortality: A national COVID cohort collaborative study, Meera Mohan, Nathaniel Verhagen, Aditya Shreenivas, et al. (Abstract)
BRE12-158: A postneoadjuvant, randomized phase II trial of personalized therapy versus treatment of physician's choice for patients with residual triple-negative breast cancer, Bryan P. Schneider, Guanglong Jiang, Tarah J. Ballinger, et al. (Article)
Characteristics of patients with hematologic malignancies without seroconversion post-COVID19 third vaccine dosing (3V): Real-world data from large midwestern healthcare system, Sigrun Hallmeyer, Michael A. Thompson, Veronica Fitzpatrick, et al. (Abstract)
Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma, Benjamin A. Derman, Andrzej J. Jakubowiak, and Michael A. Thompson (Letter)
COVID-19 vaccine effectiveness in patients with hematologic malignancy, Dimpy P. Shah, Pankil K. Shah, and Michael A. Thompson (Editorial)
General surgery training in the USA, UK, and India: A scrutiny of strength and challenges, Gaurav Jain, Chandrakanth Are, Vikesh Agrawal, et al. (Article)
Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: A cohort study from the COVID-19 and Cancer Consortium, Arielle Elkrief, Cassandra Hennessy, Nicole M. Kuderer, et al. (Article)
HealthTree Cure Hub: A patient-derived, patient-driven clinical cancer information platform used to overcome hurdles and accelerate research in multiple myeloma, Nathan W. Sweeney, Jennifer M. Ahlstrom, Faith E. Davies, et al. (Article)
Impact of donation aftercirculatory death allografts on outcomes after liver transplant for hepatitis C: A single-center experience and review of the literature, Shiva Kumar, Rachel Pedersen, and Ajay Sahajpal (Article)
Neoadjuvant chemotherapy is associated with improved outcomes in patients with stage 1A and 1B pancreatic cancer undergoing surgery: An NCDB study, Noah Rozich, Maharaj Singh, Isaac Kriley, et al. (Abstract)
Online medical misinformation in cancer: Distinguishing fact from fiction, Eleonora Teplinsky, Sara Beltrán Ponce, Emily K. Drake, et al. (Article)
Pilot study to reliably measure the tissue concentration of mitomycin c after hyperthermic intraperitoneal chemotherapy in patients with gastrointestinal malignancies, Isaac Kriley, Noah Rozich, Geoffrey Bellini, et al. (Abstract)
Pre-operative embolization, surgical resection, and follow-up evaluation of a giant intercostal schwannoma, Mason A. Brown, JiaHao Hu, William Tisol, et al. (Article)
Quantifying the value of the molecular tumor board: Discordance recommendation rate and drug cost avoidance, Mary K. Walters, Andrew T. Ackerman, James L. Weese, et al. (Article)
Racial disparities in COVID-19 outcomes among black and white patients with cancer, Julie Fu, Sonya A. Reid, Michael Thompson, et al. (Article)
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies, Michael A. Thompson, Sigrun Hallmeyer, Veronica E. Fitzpatrick, Yunqi Liao, Michael P. Mullane, Stephen C. Medlin, Kenneth Copeland, and James L. Weese (Original Research)
Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis, Sushmita Gordhandas, Brooke A. Schlappe, Qin Zhou, et al. (Article)
Social media and professional development for oncology professionals, Anusha Chidharla, Audun Utengen, Deanna J. Attai, et al. (Article)
Works from 2021
Abstract 2618: Staged analysis of standard of care tumor molecular testing among patients with metastatic colorectal cancer in the community health system setting, Michael A. Thompson, Anthony Ruggeri, Jennifer Godden, et al. (Abstract)
Abstract p159: molecular tumor board impact at two large health systems, Jennifer Godden, Michael A. Thompson, James Weese, et al. (Abstract)
Abstract PS7-01: Characteristics and outcomes of SARS-CoV-2 infection in patients with invasive breast cancer (BC) from the COVID-19 and cancer consortium (CCC19) cohort study, Ali Raza Khaki, Dimpy Shah, Michael A. Thompson, et al. (Abstract)
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium, P Grivas, A R Khaki, T M Wise-Draper, et al. (Article)
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19, Michael A. Thompson, Jeffrey P Henderson, Pankil K Shah, et al. (Article)
Care without a compass: including patients with cancer in COVID-19 studies, Christopher R Friese, Toni K Choueiri, Narjust Duma, et al. (Article)
COVID-19 and cancer: A review of the registry-based pandemic response, Aakash Desai, Turab J Mohammed, Narjust Duma, et al. (Article)
Dosimetric benefits of omitting primary tumor beds in postoperative radiotherapy after transoral robotic surgery using the auto-planning technique, Taoran Cui, Matthew C. Ward, Jeffrey A. Kittel, et al. (Article)
ECOG-ACRIN EAA181: Effective quadruplet utilization after treatment evaluation (EQUATE)—a randomized phase 3 trial for newly diagnosed multiple myeloma (NDMM) not intended for early autologous transplantation, Shaji Kumar, Zihan Wei, Michael A. Thompson, et al. (Abstract)
Identification of potential germline (GL) variants by routine clinical comprehensive genomic profiling (CGP) and confirmatory GL testing in 24 tumor types, Kristen Hanson, Michael P. Mullane MD, Deborah Wham, et al. (Abstract)
Impact of the COVID-19 pandemic on oncologist burnout, emotional well-being, and moral distress: Considerations for the cancer organization's response for readiness, mitigation, and resilience, Fay J Hlubocky, Banu E Symington, Daniel C McFarland, et al. (Article)
Ixazomib-lenalidomide-dexamethasone in routine clinical practice: effectiveness in relapsed/refractory multiple myeloma, Roman Hájek, Jiří Minařík, Jan Straub, et al. (Article)
Modernizing clinical trial eligibility criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group, Alexander I Spira, Mark D Stewart, Suzanne Jones, et al. (Article)
Molecular biomarker testing and targeted therapy patterns in patients with acute myelogenous leukemia (aml) in community health systems in the united states: a real-world data analysis, Zartash Gul and Michael A. Thompson (Abstract)
MPN-390: Study design and objectives for a new cohort of patients with myelofibrosis (MF) enrolled in the ongoing Connect® Myeloid Disease Registry, John Mascarenhas, Michael Savona, Michael A. Thompson, et al. (Abstract)
Myocarditis as a rare, yet serious adverse event associated with immune checkpoint inhibitors in patients with non-small cell lung cancer: Case series from a large community-based cancer center, Mohamed Hendawi, Luke Peterson, Eyob Tadesse, et al. (Abstract)
Oncofetal chondroitin sulfate is a highly expressed therapeutic target in non-small cell lung cancer, Htoo Zarni Oo, Zoltan Lohinai, Nastaran Khazamipour, et al. (Article)
P10.03 Pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis of key prognostic factors, S Gadgeel, Mohamed Hendawi, James Weese, et al. (Abstract)
P10.04 Immunotherapy-treated non-small cell lung cancer patients with sensitizing gene alterations: A real world survival analysis, L Khaddour, Eyob Tadesse, Michael A. Thompson, et al. (Abstract)
People with cancer are likely to accept the covid-19 vaccine, but politics tracks with attitudes: An inspire and cosmo survey, Don Dizon, Kathleen Hoffman, Michael A. Thompson, et al. (Abstract)
Prognostic Implications of Vitamin D in Patients With a Hematologic Malignancy at a Large Health System in Wisconsin, Daniel Mundt, Marianne Klumph, Kayla Heslin, and Michael A. Thompson (Abstract)
Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems, Clara Hwang, Monika A Izano, Michael A. Thompson, et al. (Article)
Real-world comparative effectiveness of triplets containing bortezomib (B), carfilzomib (C), daratumumab (D), or ixazomib (I) in relapsed/refractory multiple myeloma (RRMM) in the US, Faith Davies, Robert Rifkin, Caitlin Costello, et al. (Article)
Real-world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower-risk myelodysplastic syndromes, Jay L Patel, Mehrdad Abedi, Christopher R Cogle, et al. (Article)
Real-world performance of a comprehensive genomic profiling test optimized for small tumor samples, Scott A. Tomlins, Daniel H. Hovelson, Jennifer M. Suga, et al. (Article)
Recommendations to streamline and standardize clinical trial site feasibility assessments: An ASCO research statement, Dax Kurbegov, Patricia Hurley, David M Waterhouse, et al. (Article)
Reduced blood product utilization via implementation of an anemia clinic and consult service in a large health system hospital, Reid Christian Bowers, Sandra Tomany Korman, Michael A. Thompson, et al. (Abstract)
Refining a Postpandemic Approach to Cancer Screening, Michael A. Thompson (From the Editor)
The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19, Ang Li, Nicole M Kuderer, Chih-Yuan Hsu, et al. (Article)
Treatment patterns and survival outcomes of patients with acute myeloid leukemia who achieved remission in the connect ® myeloid disease registry, Michael A. Thompson (Abstract)
Use of convalescent plasma in COVID-19 patients with immunosuppression, Jonathon W Senefeld, Stephen A Klassen, Shane K Ford, et al. (Article)
Works from 2020
Association of circulating tumor DNA and circulating tumor cells after neoadjuvant chemotherapy with disease recurrence in patients with triple-negative breast cancer: Preplanned secondary analysis of the BRE12-158 randomized clinical trial, Milan Radovich, Guanglong Jiang, Bradley A Hancock, et al. (Article)
A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance, M Abidi, DM Aboulafia, Michael A. Thompson, et al. (Article)
Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh-frozen plasma, Mehraboon S. Irani, Federico Sanchez, and Kenneth Friedman (Article)
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study, Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, et al. (Article)
Clinical impact of COVID-19 on patients with cancer: Data from the COVID-19 and Cancer Consortium (CCC19), Jeremy L Warner, Sam Rubinstein, and Michael A. Thompson (Abstract)
Comparing survival outcomes for neoadjuvant therapy versus adjuvant therapy in the management of stage 1 pancreatic adenocarcinoma: A National Cancer Database study, Samit K. Datta, Geoffrey Bellini, Maharaj Singh, et al. (Abstract)
Comprehensive genomic profiling of 30,000 consecutive solid tumors, Michael Thompson (Article)
Concordant genomic vulnerabilities of patient-derived cell line and matched xenograft-derived cell line through whole exome sequencing in breast-brain metastatic cancer, Jun Yin, Aspen T. Duffin, Kate Dennert, et al. (Article)
Crowdsourcing a crisis response for COVID-19 in oncology, Aakash Desai, Jeremy Warner, Nicole Kuderer, et al. (Article)
Diagnostic and molecular testing patterns in patients with newly diagnosed acute myeloid leukemia in the Connect® MDS/AML Disease Registry, Daniel A. Pollyea, Tracy I. George, Michael A. Thompson, et al. (Article)
HealthTree Patient Portal mediated myeloma patient-reported vaccination and antibiotic use, Michael A. Thompson, Jenny Ahlstrom, and Nathan W. Sweeney (Abstract)
Impact on patient outcomes of creating a robotic complex pancreatic surgery training program, Nicholas Sich, Geoffrey Bellini, James Weese, et al. (Poster)
Incidence of and risk factors for venous thromboembolism among hospitalized patients with cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry, Ang Li, Nicole M Kuderer, Jeremy L. Warner, et al. (Abstract)
LBA72 Assessment of clinical and laboratory prognostic factors in patients with cancer and SARS-CoV-2 infection: The COVID-19 and Cancer Consortium (CCC19), P Grivas, J Warner, Michael A. Thompson, et al. (Abstract)
Molecular alterations with hyperprogression in lung cancer patients treated with immune checkpoint inhibitors in a large health system, Eyob Tadesse, Kayla Heslin, Mohamed Hendawi, et al. (Abstract)
Multiple myeloma (MM) vaccination (influenza, FV and pneumococcal, PV) rates worldwide and impact on infection, hospitalization, and death, Michael A. Thompson, Caitlin Costello, and et al (Abstract)
Oncologic outcomes of robotic compared to open pancreatic surgery: A National Cancer Database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, et al. (Poster)
Oncology precision medicine for hepatobiliary and pancreatic cancer: Insights and updates from a large community health system, Geoffrey Bellini, Nicholas Sich, Jennifer Godden, et al. (Poster)